TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
IFRX

InflaRx N.V.

Healthcare · Biotechnology

1.80$ -3.7% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement IFRX
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – 100.0% – – – – – 100.0% 100.0% 100.0%
– – 28.9% – – – – – 843.7% 2,000.8% 24,777.9%
– – -29.6% – – – – – -743.7% -1,900.8% -24,677.9%
– – 6,240.3% – – – – – 65,025.8% 21,330.7% 87,691.5%
– – 2,224.2% – – – – – 22,533.9% 9,219.7% 52,908.3%
– – 8,127.4% – – – – – 69,942.0% 30,010.6% 139,847.6%
– – -8,417.7% – – – – – -70,685.6% -31,911.4% -164,525.5%
– – 964.9% – – – – – 56.5% 12.5% 128.5%
– – -10,492.6% – – – – – -67,630.7% -27,781.8% -155,540.2%
– – 964.9% – – – – – 0.0% 3.1% 41.9%
– – -10,492.6% – – – – – -67,630.7% -27,785.0% -155,582.1%
– – -8,476.2% – – – – – -66,674.3% -27,476.7% -153,976.3%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?